rss
Evid Based Nurs 12:57 doi:10.1136/ebn.12.2.57
  • Treatment

High-dose vitamin B supplements did not slow cognitive decline in patients with mild-to-moderate Alzheimer disease

P S Aisen

Dr P S Aisen, University of California, San Diego, CA, USA; paisen@ucsd.edu

QUESTION

Do high-dose vitamin B supplements reduce rate of cognitive decline in patients with Alzheimer disease (AD)?

METHODS

Design:

randomised placebo controlled trial. Clinicaltrials.gov NCT00056225.

Allocation:

{concealed}.*

Blinding:

blinded (patients, caregivers, clinicians, and psychometrists).

Follow-up period:

every 3 months up to 18 months.

Setting:

40 centres in the USA.

Patients:

409 patients >50 years of age (mean age 76 y, 56% women), who had probable AD, scored 14–26 on the Mini-Mental State Examination (MMSE), and were medically stable. Exclusion criteria were vitamin B12 concentrations <129 pmol/l (175 pg/ml), folate concentrations <9.5 nmol/l (4.2 ng/ml), renal insufficiency (serum creatinine ⩾176.8 µmol/l [2.0 mg/dl]), …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article